A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus

Clinical trial NCT07509892 · RECRUITING

Trial details

NCT number: NCT07509892
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2026-06-22
Primary completion: 2027-11-01
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.